N/A
N=30
Mobile Intervention for Veterans With PTSD and Anger
Posttraumatic Stress Disorder · Anger
Bottom Line
View on ClinicalTrials.gov: NCT03733028 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcome: Primary: Feasibility as Measured by Percentage of Recruitment Goal Met — 16; 14 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Mobile Intervention for Reducing Anger (MIRA) (Behavioral); Mindfulness Intervention (Behavioral)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Apr 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility as Measured by Percentage of Recruitment Goal Met |
16; 14 | — |
| PRIMARY Number of Participants Lost to Attrition During Treatment |
0; 1 | — |
| PRIMARY Number of Participants Who Report Satisfaction With the MIRA App |
14 | — |
| PRIMARY Average Number of Treatment Sessions Completed by MIRA App Users |
17.13 | — |
Summary
Anger is the mostly commonly reported reintegration concern among combat Veterans, especially those with PTSD. Problematic anger is associated with significant functional impairment. In the current project, the investigators will pilot-test a newly developed mobile app, entitled Mobile Intervention for Reducing Anger (MIRA), among Veterans with PTSD and problematic anger. The project will compare the MIRA app to a contact control condition. The investigators hypothesize that Veterans with PTSD and problematic anger will find the MIRA app acceptable and will be willing to use it to reduce their anger difficulties and improve psychosocial and occupational functioning.
Eligibility Criteria
Inclusion Criteria
- Veterans diagnosed with PTSD, established via the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
- Reporting a score of 12 on the 5-item Dimensions of Anger Reactions Scale
- Able to read at least 6th grade level material
Exclusion Criteria
- Expect to be unstable on their medication regimen during the study
- Currently in a period of active psychosis or mania
- Exhibit current prominent suicidal or homicidal ideation requiring immediate intervention
- Receiving (or plan to receive) other anger management psychotherapy or trauma-focused therapy for PTSD (i.e., prolonged exposure, cognitive processing therapy during the course of the study
Data sourced from ClinicalTrials.gov (NCT03733028). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.